<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02617095</url>
  </required_header>
  <id_info>
    <org_study_id>LT2762-PIV-11/13</org_study_id>
    <nct_id>NCT02617095</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome</brief_title>
  <official_title>Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Thea</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Thea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of T2762 versus Optive® in
      the treatment of moderate to severe Dry Eye Syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    recruitment rate too slow
  </why_stopped>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the symptomatology evaluation on a Visual Analogic Scale</measure>
    <time_frame>Day 28</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>T2762</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One drop of T2762 in each eye 3 to 6 times daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One drop of Optive in each eye 3 to 6 times daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>T2762</intervention_name>
    <description>One drop in each eye 3 to 6 times daily</description>
    <arm_group_label>T2762</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optive</intervention_name>
    <description>One drop in each eye 3 to 6 times daily</description>
    <arm_group_label>Optive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed and dated informed consent.

          -  Male or female aged ≥ 18 years old.

          -  Diagnosis of moderate to severe dry eye syndrome

        Exclusion Criteria:

          -  Pregnancy, lactation.

          -  Childbearing potential woman who is not using a reliable method of contraception and
             is not surgically sterilised.

          -  Inability of patient to understand the study procedures and thus inability to give
             informed consent.

          -  Non-compliant patient

          -  Participation in another clinical study at the same time as the present study.

          -  Participation to the present study during the exclusion period of another clinical
             study.

          -  Already included once in this study.

          -  Ward of court.

          -  Patient not covered by government health care scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Larkin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moorfields Eye Hospital -162 city road - London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Friedrich KRUSE, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augenklinik mit Poliklinik - Swabachanlage 6 - 91054 Erlangen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratoires Théa</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2015</study_first_submitted>
  <study_first_submitted_qc>November 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2015</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

